Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 10/20 | 0.56 |
| ▸ | CA1 | P00915 | 9/20 | 0.56 |
| ▸ | CA7 | P43166 | 2/20 | 0.56 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.56 |
| ▸ | CA9 | Q16790 | 7/20 | 0.35 |
| ▸ | CA5A | P35218 | 5/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA6 | P23280 | 1/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.33 |
| ▸ | F2 | P00734 | 2/20 | 0.32 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.32 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.32 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5135851 | 0.97 | CA2 (0.53) | CA2CA1CA7CA13CA9 | |
| SCHEMBL5134956 | 0.97 | CA2 (0.53) | CA2CA1CA7CA13CA9 | |
| Lithium SCHEMBL30726243 | 0.97 | CA2 (0.53) | CA2CA1CA7CA13CA9 | |
| SCHEMBL3432336 | 0.97 | CA2 (0.53) | CA2CA1CA7CA13CA9 | |
| SCHEMBL867460 | 0.93 | CA2 (0.56) | CA2CA1CA7CA13CA9 | |
| SCHEMBL13684271 | 0.90 | CA2 (0.53) | CA2CA1CA7CA13CA9 | |
| SCHEMBL4463838 | 0.90 | CA2 (0.53) | CA2CA1CA7CA13CA9 | |
| SCHEMBL4533894 | 0.87 | CA2 (0.50) | CA2CA1CA7CA13CA9 | |
| SCHEMBL12693515 | 0.86 | CA1 (0.43) | CA2CA1CA7CA13CA9 | |
| SCHEMBL16340930 | 0.85 | CA1 (0.64) | CA2CA1CA7CA13CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260005297-A1 | SOLID ELECTROLYTE | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2026-01-01 | — | — | US | claimed |
| WO-2024191177-A1 | POSITIVE ELECTRODE FOR ALL-SOLID-STATE RECHARGEABLE BATTERY AND ALL-SOLID-STATE RECHARGEABLE BATTERY INCLUDING SAME | 삼성에스디아이 주식회사 | 2024-09-19 | — | — | WO | claimed |
| CN-117712476-A | Gel quasi-solid electrolyte and lithium battery prepared from same | 湖南大学 | 2024-03-15 | — | — | CN | claimed |
| US-20240069442-A1 | PHOTOACID GENERATOR | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2024-02-29 | — | — | US | claimed |
| US-20220163886-A1 | PHOTOACID GENERATOR | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2022-05-26 | — | — | US | claimed |
| CN-114524840-A | Photoacid generators | 国际商业机器公司 | 2022-05-24 | — | — | CN | claimed |
| CN-109313398-A | It rinses composition, form the method for resist pattern and the preparation method of semiconductor devices | AZ电子材料(卢森堡)有限公司 | 2019-02-05 | — | — | CN | claimed |
| US-9631048-B2 | Sulfonium compounds, their preparation and use | BASF SE (DE) | 2017-04-25 | — | — | US | claimed |
| US-20150044509-A1 | SULFONIUM COMPOUNDS, THEIR PREPARATION AND USE | BASF SE (DE) | 2015-02-12 | — | — | US | claimed |
| EP-4682968-A1 | POSITIVE ELECTRODE FOR ALL-SOLID-STATE RECHARGEABLE BATTERY AND ALL-SOLID-STATE RECHARGEABLE BATTERY INCLUDING SAME | SAMSUNG SDI CO., LTD. (KR) | 2026-01-21 | — | — | EP | disclosed |
| EP-4682968-A1 | POSITIVE ELECTRODE FOR ALL-SOLID-STATE RECHARGEABLE BATTERY AND ALL-SOLID-STATE RECHARGEABLE BATTERY INCLUDING SAME | SAMSUNG SDI CO., LTD. (KR) | 2026-01-21 | — | — | EP | disclosed |
| US-20260005297-A1 | SOLID ELECTROLYTE | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2026-01-01 | — | — | US | disclosed |
| US-20260005297-A1 | SOLID ELECTROLYTE | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2026-01-01 | — | — | US | disclosed |
| US-12500273-B2 | Electrolytic solution, secondary battery, and power consumption apparatus | CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) | 2025-12-16 | — | — | US | disclosed |
| US-20160231652-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-08-11 | — | — | US | disclosed |
| US-20150044509-A1 | SULFONIUM COMPOUNDS, THEIR PREPARATION AND USE | BASF SE (DE) | 2015-02-12 | — | — | US | disclosed |
| US-8440365-B2 | Electrolyte, production process therefor, electrolyte membrane, production process therefor, catalyst layer and fuel cell | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2013-05-14 | — | — | US | disclosed |
| US-20090247736-A1 | Luminous Compound Containing Lanthanide Ion | FUJIFILM CORPORATION (JP) | 2009-10-01 | — | — | US | disclosed |
| US-7592375-B2 | Ion conductive polymers and imide monomers | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2009-09-22 | — | — | US | disclosed |
| US-20090191442-A1 | Electrolyte, production process therefor, electrolyte membrane, production process therefor, catalyst layer and fuel cell | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2009-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260005297-A1 | SOLID ELECTROLYTE | SLC9A2, SCNN1A, LSG1 | CA2 607/4885CA1 858/4885CA7 2209/4885 |
| US-20150044509-A1 | SULFONIUM COMPOUNDS, THEIR PREPARATION AND USE | SQOR, ACSL3, ARSA | CA2 479/4885CA1 323/4885CA7 245/4885 |
| US-20090247736-A1 | Luminous Compound Containing Lanthanide Ion | COG1, LCT, L3MBTL1 | CA2 1018/4885CA1 455/4885CA7 486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.